DOI: 10.12890/2024_004850

Calcified maxillary fibroma in a patient on hemodialysis for seven years

Authors

  • Wachid Putranto Kidney and Hypertension Division, Department of Internal Medicine, Sebelas Maret University Hospital, Sukoharjo, Indonesia; Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia
  • Yeremia Suryo Pratama Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia; Hemodialysis Unit, Indriati Hospital Solo Baru, Sukoharjo, Indonesia
  • Krisandryka Krisandryka Hemodialysis Unit, Indriati Hospital Solo Baru, Sukoharjo, Indonesia
  • Eko Adi Pangarso Hematology Medical Oncology Division, Kariadi General Hospital, Semarang, Indonesia; Faculty of Medicine, Diponegoro University, Semarang, Indonesia
  • Meira Dewi Kusuma Astuti Faculty of Medicine, Diponegoro University, Semarang, Indonesia
  • Nurhasan Agung Prabowo Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia; Department of Internal Medicine, Sebelas Maret University Hospital, Sukoharjo, Indonesia 0000-0003-2016-5649

dr.Nurhasan21@staff.uns.ac.id

Keywords

CKD-MBD, complication, hemodialysis, histopathology, parathyroid

Abstract

Background: The presentation of mineral bone disorder (MBD) in individuals with chronic kidney disease (CKD) may vary. Consequently, physicians should be capable of recognising this condition when there is a suspicion of its existence. This case report will describe a calcified maxilla tumour as a manifestation of CKD-MBD.
Case description: Initially asymptomatic, a 32-year-old female presented with progressive swelling of the upper left jaw. She had a history of routine haemodialysis. Further laboratory, radiological, and histopathological workup revealed the mass was indeed calcified maxillary fibroma arising from the manifestation of CKD-MBD.
Conclusion: This study underscores the significance of clinical comprehension of the broad-spectrum manifestations of CKD-MBD, including an initially asymptomatic mass. In addition, the screening of the patient’s biochemical was required to determine the necessity of early intervention and improve the patient’s outcome.

View the entire article

Downloads

References

  1. Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide, over 850 million individuals have kidney diseases. Nephrology Dialysis Transplantation 2019;34:1803–1805.
  2. Hu L, Napoletano A, Provenzano M, Garofalo C, Bini C, Comai G, et al. Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic. IJMS 2022;23:12223.
  3. Vervloet MG, Massy ZA, Brandenburg VM, Mazzaferro S, Cozzolino M, Ureña-Torres P, et al. Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. Lancet Diabetes Endocrinol 2014;2:427–436.
  4. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006;69:1945–1953.
  5. Wiederkehr M. Brown tumor complicating end-stage kidney disease. Clin Nephrol Case Stud. 2020;8:72–79.
  6. Shetty AD, Namitha J, James L. Brown Tumor of Mandible in Association with Primary Hyperparathyroidism: A Case Report. J Int Oral Health. 2015;7:50–52.
  7. Manjunatha BS, Purohit S, Harsh A, Vangala N. A complex case of brown tumours as the initial manifestation of primary hyperparathyroidism in a young female. J Oral Maxillofac Pathol 2019;23:477.
  8. Jebasingh F, Jacob JJ, Shah A, Paul TV, Seshadri MS. Bilateral maxillary brown tumours are the first primary hyperparathyroidism presentation. Oral Maxillofac Surg 2008;12:97–100.
  9. Selvi F, Cakarer S, Tanakol R, Guler SD, Keskin C. Brown tumour of the maxilla and mandible: a rare complication of tertiary hyperparathyroidism. Dentomaxillofac Radiol 2009;38:53–58.
  10. Goltzman D, Mannstadt M, Marcocci C. Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis. 2018 Mar 29 [cited 2024 May 30]; Available from: https://karger.com/books/book/134/chapter/5071932/Physiology-of-the-Calcium-Parathyroid-Hormone
  11. Cunningham J, Locatelli F, Rodriguez M. Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options. Clin J Am Socy Nephrol 2011;6:913.

Published

2024-09-03

How to Cite

1.
Putranto W, Pratama YS, Krisandryka K, Pangarso EA, Astuti MDK, Prabowo NA. Calcified maxillary fibroma in a patient on hemodialysis for seven years. EJCRIM [Internet]. 2024 Sep. 3 [cited 2026 Nov. 14];11(10). Available from: https://ejcrim.com/index.php/ejcrim/article/view/4850

Most read articles by the same author(s)